2018 Nobel Prize in Medicine

Anybody make a connection between the work performed by Japanese Professor Prof Takusu Honjo and the work being completed by Cellmid also originating in Japan. Although different Proteins the similarities are remarkably similar in action by promoting T Cells that fight Cancer Cells.

I think today's extra volume was someone else joining the same dots.  Remember Volume precedes price.

https://www.iflscience.com/health-and-medicine/cancer-researchers-win-2018-nobel-prize-for-medicine/

Extract
"Certain proteins appear to inhibit the action of the immune system by acting as "brakes". Removing these proteins from the equation allows immune cells called T-cells to attack the cancer."

Celmid's Antibody CAB101

CAB101 is a monoclonal antibody targeting MK for the treatment of kidney injury, inflammatory and fibrotic diseases. In vivo pre-clinical studies in various animal models of inflammation and autoimmunity have shown that the murine version of the antibody ameliorates disease by reducing inflammatory cell infiltration and increasing regulatory T cell numbers. No off target toxicities have been observed. Pre-clinical studies of CAB101 are ongoing.